Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1

Andrew L. Mammen, Arun Rajan, Katherine Pak, Tanya Lehky, Livia Casciola-Rosen, Renee N. Donahue, Lauren M. Lepone, Anastasia Zekeridou, Sean J. Pittock, Raffit Hassan, Jeffrey Schlom, James L. Gulley

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1'. Together they form a unique fingerprint.